If You Invested in ProShares Ultra CRCL (CRCA)
Looking for the current price? See the CRCA quote & overviewWhat $1,000 or $10,000 in CRCA Would Be Worth Now
Real historical value by amount invested and how long ago| If you invested | 1 year ago | 5 years ago | 10 years ago | Since Aug 7, 2025 |
|---|---|---|---|---|
| $1,000 | $156 -84% | — | — | $52 -95% |
| $10,000 | $1,557 -84% | — | — | $515 -95% |
Based on real historical closing prices adjusted for stock splits, without dividends, through 2026-11-05. Figures with dividends reinvest each cash dividend at the previous close less the dividend, before taxes. Past performance does not guarantee future results.
Custom Calculation
Choose your own date and amount for CRCA$1,000 Investment Over Time
CRCA vs S&P 500Year-by-Year Returns
CRCA annual performance| Year | Start Price | End Price | Annual Return | Cumulative |
|---|---|---|---|---|
| 2025Aug 7, 2025 to Dec 31, 2025 | $223.50 | $40.40 | -81.9% | -81.9% |
| 2026Dec 31, 2025 to Nov 5, 2026 | $40.40 | $11.52 | -71.5% | -94.8% |
About ProShares Ultra CRCL
NYSE
ProShares Ultra CRCL (CRCA) is an exchange-traded fund offered by ProShares, an ETF sponsor known for geared strategies, including leveraged and inverse ETF investing. The fund is part of a ProShares lineup that includes products tied to dividend growth, high income, interest-rate-hedged bonds, crypto exposure, and tactical ETF strategies.
As a ProShares ETF, ProShares Ultra CRCL is associated with fund-level mechanics and risks typical of the sponsor's geared products. ProShares materials describe its ETFs as generally non-diversified and note that certain funds may use derivatives such as swap agreements, futures contracts, and similar instruments. These instruments, along with leverage, imperfect benchmark correlation, and market price variance, can increase volatility and affect fund performance.
Recent ProShares fund communications also address ETF share actions such as reverse share splits. A reverse split changes the number of shares outstanding and the per-share trading price but does not, by itself, change the total value of a shareholder's investment. CRCA's public-company profile is therefore best understood as a fund reference record tied to ProShares' ETF platform rather than as an operating business with products, customers, or operating segments.
Frequently Asked Questions
ProShares Ultra CRCL investment returns
How much would $1,000 invested in ProShares Ultra CRCL be worth today?
If you invested $1,000 in ProShares Ultra CRCL (CRCA) 1 year ago on 2025-11-06, your investment would be worth $156 as of 2026-11-05, a -84.4% price return without dividends, growing at a compounded rate of -84.5% per year (CAGR).
Has ProShares Ultra CRCL outperformed the S&P 500?
Comparison data requires at least 10 years of trading history. Use the calculator above to compare CRCA performance over available time periods.
For informational and educational purposes only, not investment advice.
